Unicycive Therapeutics, Inc. (UNCY)
3.585
-0.12
(-3.11%)
USD |
NASDAQ |
Oct 15, 16:00
3.65
+0.06
(+1.81%)
After-Hours: 20:00
Unicycive Therapeutics Market Cap : 99.86M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 103.06M |
| October 13, 2026 | 103.90M |
| October 12, 2026 | 112.81M |
| October 09, 2026 | 114.49M |
| October 08, 2026 | 113.37M |
| October 07, 2026 | 116.44M |
| October 06, 2026 | 117.83M |
| October 05, 2026 | 116.71M |
| October 02, 2026 | 117.55M |
| October 01, 2026 | 126.74M |
| September 30, 2026 | 130.78M |
| September 29, 2026 | 126.74M |
| September 28, 2026 | 129.25M |
| September 25, 2026 | 130.78M |
| September 24, 2026 | 133.98M |
| September 23, 2026 | 133.98M |
| September 22, 2026 | 138.16M |
| September 21, 2026 | 132.87M |
| September 18, 2026 | 133.71M |
| September 17, 2026 | 132.87M |
| September 16, 2026 | 133.15M |
| September 15, 2026 | 131.20M |
| September 14, 2026 | 143.45M |
| September 11, 2026 | 147.35M |
| September 10, 2026 | 147.91M |
| Date | Value |
|---|---|
| September 09, 2026 | 142.62M |
| September 08, 2026 | 140.11M |
| September 04, 2026 | 143.73M |
| September 03, 2026 | 147.63M |
| September 02, 2026 | 144.57M |
| September 01, 2026 | 140.67M |
| August 31, 2026 | 144.85M |
| August 28, 2026 | 146.66M |
| August 27, 2026 | 153.20M |
| August 26, 2026 | 151.25M |
| August 25, 2026 | 152.37M |
| August 24, 2026 | 148.75M |
| August 21, 2026 | 156.83M |
| August 20, 2026 | 151.81M |
| August 19, 2026 | 155.43M |
| August 18, 2026 | 156.83M |
| August 17, 2026 | 155.15M |
| August 14, 2026 | 153.48M |
| August 13, 2026 | 150.42M |
| August 12, 2026 | 150.14M |
| August 11, 2026 | 139.28M |
| August 10, 2026 | 139.83M |
| August 07, 2026 | 141.23M |
| August 06, 2026 | 127.45M |
| August 05, 2026 | 131.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.389B |
| Alnylam Pharmaceuticals, Inc. | 31.29B |
| Anika Therapeutics, Inc. | 277.16M |
| Savara, Inc. | 976.67M |
| Vericel Corp. | 2.099B |
Market Cap Related Metrics
| Price to Book Value | 1.875 |
| Price | 3.585 |
| Earnings Yield | -44.53% |